(11) 98705-3426
TrademarkIQ iconTrademarkIQ
Back to search
Official data from USPTO

MERIDIAN BIOSCIENCE

Did you know this trademark is already registered in United States?

Before investing in name, identity, and promotion, validate collision risk and registration strategy to avoid wasting time and budget.

Active USPTO registrationType: WordOffice: United States

Quick snapshot

MERIDIAN BIOSCIENCE

ST13

US500000087905862

Class

1, 5, 10

Filing

87905862

Registration

5915740

Risk and opportunity diagnosis

Executive reading for naming, filing, and monitoring decisions.

USPTO status

Active USPTO registration

Case type

Application and registration

Recorded events

33

Latest update

03/20/2025

Trademark type

Word

Nice classes

1, 5, 10

Filing date

05/03/2018

Registration date

11/19/2019

Expiration date

-

Complete case details

Structured fields from the responsible authority and the official record.

Status date

03/19/2025

Last transaction

03/20/2025

Responsible office

United States Patent and Trademark Office

Status code

702

Official register

Principal Register

Filing basis

Intent to use

First use anywhere

01/24/2001

First use in commerce

01/24/2001

Drawing code

4

Owner type

03

Owner location

Cincinnati, OH

Examiner

LEE,REBECCA ANN

Current location

Historical data usage

Holders and representatives

Holders

Meridian Bioscience, Inc.

Representatives

J. Michael Hurst KEATING MUETHING & KLEKAMP PLL

Technical classification

Nice Classes

Class 1Class 5Class 10

Vienna Codes

No Vienna codes available.

Goods and services

Class 1

diagnostic reagents for scientific use; reagents for scientific or medical research use; diagnostic reagents for clinical or medical laboratory use; diagnostic reagents for in vitro use in biochemistryclinical chemistry and microbiology; laboratory chemicalsan antibody reagent used for the detection of antigens in cell and tissue analysis for in vitro diagnostic use; biochemicalsmonoclonal antibodies for in vitro scientific or research use; chemicals for use in the purification of proteins for in vitro use; protein in raw material form for scientific and medical research; enzymes for scientific and research purposes

Class 5

diagnostic kits consisting primarily of monoclonal antibodiesbuffersreagents for use in disease testing; medical diagnostic reagents and assays for testing of body fluids; medical diagnostic reagents; clinical medical reagents; reagent paper for medical purposes; diagnostic biomarker reagents for medical purposes; protein arrays for medical diagnosis purposes; enzyme preparations for medical purposes

Class 10

medical diagnostic machinesimmunoassay readers used to detect and measure antigens and antibodies; medical diagnostic instruments for the analysis of body fluids; sample preparation device for medical diagnostic uses; medical diagnostic apparatus for detecting gastrointestinal diseasesviral diseasesurinary diseasesrespiratory diseasesinfectious diseases

Publications

History of USPTO decisions and trademark events.

33 publications found

NA85

NOTICE OF ACCEPTANCE OF SEC. 8 & 15 - E-MAILED

03/19/2025

C15A

REGISTERED - SEC. 8 (6-YR) ACCEPTED & SEC. 15 ACK.

03/19/2025

APRE

CASE ASSIGNED TO POST REGISTRATION PARALEGAL

03/19/2025

E815

TEAS SECTION 8 & 15 RECEIVED

11/22/2024

REM1

COURTESY REMINDER - SEC. 8 (6-YR) E-MAILED

11/19/2024

R.PR

REGISTERED-PRINCIPAL REGISTER

11/19/2019

SUNA

NOTICE OF ACCEPTANCE OF STATEMENT OF USE E-MAILED

10/18/2019

CNPR

ALLOWED PRINCIPAL REGISTER - SOU ACCEPTED

10/17/2019

TEME

TEAS/EMAIL CORRESPONDENCE ENTERED

10/17/2019

CRFA

CORRESPONDENCE RECEIVED IN LAW OFFICE

10/17/2019

TROA

TEAS RESPONSE TO OFFICE ACTION RECEIVED

10/14/2019

GNRN

NOTIFICATION OF NON-FINAL ACTION E-MAILED

10/11/2019

GNRT

NON-FINAL ACTION E-MAILED

10/11/2019

CNRT

SU - NON-FINAL ACTION - WRITTEN

10/11/2019

SUPC

STATEMENT OF USE PROCESSING COMPLETE

10/04/2019

AITU

CASE ASSIGNED TO INTENT TO USE PARALEGAL

10/04/2019

IUAF

USE AMENDMENT FILED

09/12/2019

EISU

TEAS STATEMENT OF USE RECEIVED

09/12/2019

NOAM

NOA E-MAILED - SOU REQUIRED FROM APPLICANT

04/09/2019

NPUB

OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED

02/12/2019

PUBO

PUBLISHED FOR OPPOSITION

02/12/2019

NONP

NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED

01/23/2019

ALIE

ASSIGNED TO LIE

01/07/2019

CNSA

APPROVED FOR PUB - PRINCIPAL REGISTER

12/12/2018

TEME

TEAS/EMAIL CORRESPONDENCE ENTERED

12/03/2018

CRFA

CORRESPONDENCE RECEIVED IN LAW OFFICE

12/03/2018

TROA

TEAS RESPONSE TO OFFICE ACTION RECEIVED

12/03/2018

GNRN

NOTIFICATION OF NON-FINAL ACTION E-MAILED

06/04/2018

GNRT

NON-FINAL ACTION E-MAILED

06/04/2018

CNRT

NON-FINAL ACTION WRITTEN

06/04/2018

DOCK

ASSIGNED TO EXAMINER

05/29/2018

NWOS

NEW APPLICATION OFFICE SUPPLIED DATA ENTERED

05/12/2018

NWAP

NEW APPLICATION ENTERED

05/07/2018

Continuous trademark protection

Get notified about every new filing that threatens MERIDIAN BIOSCIENCE or your mark.

Professional 24-month watch service: we monitor USPTO for you and alert you in time to oppose — before conflicts become losses.